Potential Role of Curcumin for the Treatment of Major Depressive Disorder

被引:0
|
作者
Adrian L. Lopresti
机构
[1] Clinical Research Australia,College of Science, Health, Engineering and Education
[2] Murdoch University,undefined
来源
CNS Drugs | 2022年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Curcumin is the major biologically active polyphenolic constituent in the turmeric plant (Curcuma longa) that has been shown to have antioxidant, anti-inflammatory, neuroprotective, anticancer, antimicrobial, and cardioprotective effects. Interest in curcumin as a treatment for mental health conditions has increased and there is an expanding body of preclinical and clinical research examining its antidepressant and anxiolytic effects. In this narrative review, human trials investigating the effects of curcumin for the treatment of depression or depressive symptoms are summarised. Using findings from in vitro, animal, and human trials, possible biological mechanisms associated with the antidepressant effects of curcumin are also explored. To increase the understanding of curcumin for the treatment of depression, directions for future research are proposed.
引用
收藏
页码:123 / 141
页数:18
相关论文
共 50 条
  • [1] Potential Role of Curcumin for the Treatment of Major Depressive Disorder
    Lopresti, Adrian L.
    CNS DRUGS, 2022, 36 (02) : 123 - 141
  • [2] Resolvins as potential candidates for the treatment of major depressive disorder
    Deyama, Satoshi
    Minami, Masabumi
    Kaneda, Katsuyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2021, 147 (01) : 33 - 39
  • [3] Role of trazodone in treatment of major depressive disorder: an update
    Andrea Fagiolini
    Ana González-Pinto
    Kamilla Woznica Miskowiak
    Pedro Morgado
    Allan H. Young
    Eduard Vieta
    Annals of General Psychiatry, 22
  • [4] Role of trazodone in treatment of major depressive disorder: an update
    Fagiolini, Andrea
    Gonzalez-Pinto, Ana
    Miskowiak, Kamilla Woznica
    Morgado, Pedro
    Young, Allan H.
    Vieta, Eduard
    ANNALS OF GENERAL PSYCHIATRY, 2023, 22 (01)
  • [5] Potential role of gut microbiota in major depressive disorder: A review
    Khaledi, Mansoor
    Sameni, Fatemeh
    Gholipour, Abolfazl
    Shahrjerdi, Shahnaz
    Golmohammadi, Reza
    Ghaleh, Hadi Esmaeili Gouvarchin
    Poureslamfar, Behnam
    Hemmati, Jaber
    Mobarezpour, Niloofar
    Milasi, Yaser Eshaghi
    Rad, Fatemeh
    Mehboodi, Mahtab
    Owlia, Parviz
    HELIYON, 2024, 10 (12)
  • [6] THERAPEUTIC POTENTIAL OF CONJUGATED SIRNAS FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Artigas, F.
    Bortolozzi, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 29 - 29
  • [7] The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder
    Salehpour, Farzad
    Rasta, Seyed Hossein
    REVIEWS IN THE NEUROSCIENCES, 2017, 28 (04) : 441 - 453
  • [8] Agomelatine in the Treatment of Major Depressive Disorder Potential for Clinical Effectiveness
    Kennedy, Sidney H.
    Rizvi, Sakina J.
    CNS DRUGS, 2010, 24 (06) : 479 - 499
  • [9] Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder
    Francesc Artigas
    Analia Bortolozzi
    Neuropsychopharmacology, 2017, 42 : 371 - 371
  • [10] Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder
    Artigass, Francesc
    Bortolozzi, Analia
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (01) : 371 - 372